
1. blood. 2011 jun 9;117(23):6347-54. doi: 10.1182/blood-2010-12-326876. epub 2011
apr 21.

inhibition antithrombin plasmodium falciparum histidine-rich protein ii.

ndonwi m(1), burlingame oo, miller as, tollefsen dm, broze gj jr, goldberg de.

author information: 
(1)department medicine, washington university school medicine, st louis,
mo, usa.

histidine-rich protein ii (hrpii) abundant protein released the
bloodstream plasmodium falciparum, parasite causes severe
form human malaria. here, report hrpii binds tightly selectively
to coagulation-active glycosaminoglycans (dermatan sulfate, heparan sulfate, 
heparin) inhibits antithrombin (at). purified systems, recombinant hrpii
neutralized heparin-catalyzed inhibition factor xa thrombin a
zn(2+)-dependent manner. observed 50% inhibitory concentration (ic(50)) for
the hrpii neutralization activity approximately 30nm factor xa
inhibition 90nm thrombin inhibition. zn(2+) required these
reactions distribution coefficient (k(d)) approximately 7Î¼m.
substituting zn(2+) cu(2+), ca(2+), mg(2+), fe(2+),
maintained hrpii effect. hrpii attenuated prolongation plasma clotting
time induced heparin, suggesting hrpii inhibits activity preventing
its stimulation heparin. microvasculature, erythrocytes infected 
with p falciparum sequestered, high levels released hrpii may bind
cellular glycosaminoglycans, prevent interaction at, thereby
contribute procoagulant state associated p falciparum infection.

doi: 10.1182/blood-2010-12-326876 
pmcid: pmc3122953
pmid: 21511958  [indexed medline]

